Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription 02.06.2025 1 Am J Respir Crit Care Med 1 Ann Surg Oncol 1 Anticancer Res 6 BMC Cancer 1 Clin Exp Metastasis 1 Clin Lung Cancer 1 Eur J Cardiothorac Surg 1 Int J Oncol 1 J Surg Oncol 2 J Thorac Oncol 2 JAMA Oncol 3 Lung Cancer 1 Mol Cancer Ther 1 Nat Med 1 Oncol Rep 2 PLoS One 1 Semin Oncol 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. GARSHICK E
   Lung Cancer and the Environment.
   Am J Respir Crit Care Med. 2025.
   PubMed        
   
   

   
   Ann Surg Oncol

2. NAEEM W, Khan AA, Adebayo OW, Ansari M, et al
   ASO Visual Abstract: Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17521.
   PubMed        
   
   

   
   Anticancer Res

3. OKUNO T, Hongoh M, Tanino R, Okimoto T, et al
   Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety.
   Anticancer Res. 2025;45:2551-2561.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. WU S, Qiu Z, Shi H, Yu W, et al
   High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy.
   BMC Cancer. 2025;25:926.
   PubMed         Abstract available
   
   
5. TAN M, Li L, Tan B, Yang J, et al
   Innovations in modern low-LET radiotherapy regimens for locally advanced non-small cell lung cancer: a meta-analysis and systematic review of high-dose-rate brachytherapy, stereotactic body radiotherapy, and hypofractionated proton therapy.
   BMC Cancer. 2025;25:942.
   PubMed         Abstract available
   
   
6. CHEN H, Yu Y, Zhu S, Zhao J, et al
   Impact of metabolic and nutritional disorders on the synergy between radiotherapy and immunotherapy in non-small-cell lung cancer.
   BMC Cancer. 2025;25:948.
   PubMed         Abstract available
   
   
7. MENG H, Ding RQ, Jia L, Chen XP, et al
   Photodynamic therapeutic activity of novel porphyrins against lung squamous cell carcinoma.
   BMC Cancer. 2025;25:960.
   PubMed         Abstract available
   
   
8. XING H, Wu C, Yang W, Cai S, et al
   Tracheal, bronchus, and lung cancer among older adults: thirty-year global burden trends, precision medicine breakthroughs, and lingering barriers.
   BMC Cancer. 2025;25:954.
   PubMed         Abstract available
   
   
9. RENAUD S, Casabianca P, Diez-Andreu P, Chartier M, et al
   Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study.
   BMC Cancer. 2025;25:966.
   PubMed         Abstract available
   
   

   
   Clin Exp Metastasis

10. YANG X, Chu X, Ye R, Ni J, et al
    Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectinib.
    Clin Exp Metastasis. 2025;42:31.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

11. JOSEPHIDES E, Daddi N, Bertoglio P, Lugaresi M, et al
    A Propensity-Matched Comparison Between Minimally Invasive Surgery and Stereotactic Radiotherapy in the Treatment of Clinical Stage IA Non-Small-Cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2025 Apr 29:S1525-7304(25)00083.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

12. NAKADA T, Suyama Y, Otani A, Tsukamoto Y, et al
    Resection of 4 or more pulmonary segments increases the risk of non-cancer-related mortality.
    Eur J Cardiothorac Surg. 2025;67:ezaf162.
    PubMed         Abstract available
    
    

    
    Int J Oncol

13. SHEN W, Pang H, Xin B, Duan L, et al
    [Corrigendum] Biological effects of BMP7 on small?cell lung cancer cells and its bone metastasis.
    Int J Oncol. 2025;66:51.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

14. KUSAMURA S, Cinquini M, Morris D, Piso P, et al
    Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation.
    J Surg Oncol. 2025;131:810-815.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

15. HERBST RS, Cho BC, Zhou C, Burotto M, et al
    Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous Non-Small-Cell Lung Cancer: Phase 3 LEAP-006 Study.
    J Thorac Oncol. 2025 May 24:S1556-0864(25)00724.
    PubMed         Abstract available
    
    
16. CHADDHA U, Agrawal A, Ghori U, Kheir F, et al
    Safety and Sample Adequacy for Comprehensive Biomarker Testing of Bronchoscopic Biopsies: An American Association of Bronchology and Interventional Pulmonology (AABIP) and International Association for the Study of Lung Cancer (IASLC) Clinical Practic
    J Thorac Oncol. 2025 May 24:S1556-0864(25)00722.
    PubMed         Abstract available
    
    

    
    JAMA Oncol

17. MARINELLO A, Ghigna MR, Rotow JK, Adeyelu T, et al
    Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung Cancer.
    JAMA Oncol. 2025 May 29. doi: 10.1001/jamaoncol.2025.1293.
    PubMed         Abstract available
    
    
18. ROLLE LD
    Coding Errors in Study of Lung Cancer Screening Guidelines and Adherence.
    JAMA Oncol. 2025 May 29. doi: 10.1001/jamaoncol.2025.1624.
    PubMed        
    
    

    
    Lung Cancer

19. MATSUBARA T, Shimokawa M, Wakasu S, Haro A, et al
    Controlling nutritional status predicts postoperative survival and acute exacerbation in resected non-small cell lung cancer with interstitial lung disease.
    Lung Cancer. 2025;205:108591.
    PubMed         Abstract available
    
    
20. MOORE WH, Silk M, Bhattacharji P, Pua BB, et al
    Early experience with PEF in the setting of recalcitrant stage IV lung cancer.
    Lung Cancer. 2025;204:108575.
    PubMed         Abstract available
    
    
21. NOMURA S, Sekino Y, Shiraishi Y, Toi Y, et al
    A treatment-related death predictive score for treatment-naive advanced non-small cell lung cancer.
    Lung Cancer. 2025;204:108584.
    PubMed         Abstract available
    
    

    
    Mol Cancer Ther

22. OKAWA S, Tomida S, Kuribayashi T, Nishimura J, et al
    Colony-stimulating factor-1 receptor inhibitor augments osimertinib-induced anti-tumor immunity via suppression of macrophages in lung cancer harboring EGFR mutation.
    Mol Cancer Ther. 2025 May 29. doi: 10.1158/1535-7163.MCT-25-0002.
    PubMed         Abstract available
    
    

    
    Nat Med

23. SKOULIDIS F, Li BT, de Langen AJ, Hong DS, et al
    Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer.
    Nat Med. 2025 May 28. doi: 10.1038/s41591-025-03732.
    PubMed         Abstract available
    
    

    
    Oncol Rep

24. ZINNAH KMA, Park SY
    [Corrigendum] Sensitizing TRAIL?resistant A549 lung cancer cells and enhancing TRAIL?induced apoptosis with the antidepressant amitriptyline.
    Oncol Rep. 2025;54:87.
    PubMed         Abstract available
    
    

    
    PLoS One

25. PEREZ AL, Zamora M, Bahena M, Aramburo-Williams R, et al
    The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability.
    PLoS One. 2025;20:e0316983.
    PubMed         Abstract available
    
    
26. ZHANG Y, Hu Y, Xi J, Wu B, et al
    Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small cell lung cancer.
    PLoS One. 2025;20:e0319357.
    PubMed         Abstract available
    
    

    
    Semin Oncol

27. TEGAW EM, Asfaw BB
    Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer.
    Semin Oncol. 2025;52:152364.
    PubMed         Abstract available
    
    

    
    Thorax

28. ZHANG L, Wang X, Chen Q, Zhao M, et al
    Lung cancer risk assessment by prediction model: a global perspective.
    Thorax. 2025 May 27:thorax-2023-221253. doi: 10.1136/thorax-2023-221253.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.